Dr. Steven Orland Installed as the 230th President of the Medical Society of New Jersey

25 May 2022 News

Dr. Steven Orland Urologist New JerseyDr. Steven Orland has been installed as 230th President of the Medical Society of New Jersey (MSNJ). 

At MSNJ’s 2022 Annual Meeting on Saturday, May 7, 2022, Dr. Steven Orland was installed as the 230th president of the Medical Society of New Jersey. Dr. Orland has been a member of MSNJ since 1987, and a member of the board of trustees since 2017.

In his inaugural speech, Dr. Orland shared his vision for the future of MSNJ and outlined his goals for his upcoming term:

“If the last two years has taught us anything, it is that we need to open our eyes to the larger medical world beyond the individual doctor-patient relationship.

There are significant inequalities in the healthcare system, and these became more obvious during the pandemic – things like population health, maternal health and the effects of the pandemic on minority populations.

During my presidency, I am dedicated to examining issues and discovering solutions that would improve the overall state of healthcare here in New Jersey. Some of my priorities include:

  • Further examining the prior authorization process, so that physicians can concentrate on delivering quality care and patients can receive the treatments they need without having to go through any hurdles.
  • Improving the physician workforce in New Jersey by working collaboratively with the Legislature and other stakeholders to improve the licensure process and loan forgiveness programs.
  • Promoting team-based care, with physicians leading the team, to ensure that patients receive the top-quality care they deserve.
  • Advocating for easier, quicker technology adoption in medical practices and healthcare institutions across the state, so that physicians who are interested in electronic medical records (EMR) systems and electronic health information exchanges (HIE) can easily implement and utilize them.”

Dr. Orland practices urology in Pennington, NJ, and Langhorne, PA.

READ THE FULL STORY >

New Jersey Urology Opens Cancer Care Center in Saddle Brook, NJ

New NJU cancer center in Saddle Brook, N.J., offers state-of-the-art infusion services for genitourinary cancers

We’re proud to announce the opening of New Jersey Urology (NJU) Cancer Care Center in Saddle Brook, New Jersey. Led by Dr. Elan Diamond, Medical Director of Urologic Oncology, the state-of-the-art infusion center provides treatment for prostate, bladder, kidney, penile, and testicular cancers. The new 11,500+ square-foot facility located at 160 Pehle Avenue, Suite 400, features six exam rooms and a 20-chair infusion suite that were designed to maximize patient comfort.

“We are proud to offer our patients the highest level of care possible in our new infusion center,” said Dr. Elan Diamond. “This site is the next step in our efforts to deliver state-of-the-art multidisciplinary care for our patients who are diagnosed with urologic malignancies. Here, patients will be cared for by top-notch staff, receive the latest in cancer therapies, and have the opportunity to participate in the most exciting clinical trials in the field.”

A dedicated staff includes a clinical pharmacist trained in oncology medicine, oncology-certified registered nurses, and clinical and navigation teams who work collaboratively to ensure each patient gets the personalized care and attention they need. Patients also have access to specialized on-site laboratory services and clinical research programs.

“The completed NJU Infusion Center is the crown jewel of our assets. It represents the fulfillment of our vision to provide the best possible care for our patients from initial diagnosis through treatment completion–even when that treatment requires systemic therapy for advanced disease,” said Dr. Marty Goldstein, Chief of Urology at Summit Health CityMD. “What Dr. Diamond and his exemplary staff have managed to build is truly impressive and a testament to the value they place on the patient experience.”

Congratulations to all those involved with “NJU Cancer Care Center at Saddle Brook,” the latest enhancement to Summit Health’s oncology services in northern New Jersey.

Pictured above: a ribbon-cutting ceremony with providers, staff, and company leaders marked the opening of NJU Cancer Care Center in Saddle Brook, N.J.

New Jersey Urology is now a Summit Health Company

Summit Health, the region’s premier integrated network of urgent, primary, and specialty care, today announced the additions of New Jersey Urology (“NJU”) and Westmed Medical Group (“Westmed”), a multispecialty medical practice with locations in Westchester County, NY and Fairfield County, CT.

With these new partners, Summit Health now includes more than 2,500 providers, 12,000 employees, and over 340 locations in New Jersey, New York, Connecticut, Pennsylvania, and Central Oregon, offering patients a seamless experience across a full spectrum of high-quality primary, specialty, and urgent care. Both Westmed and NJU will initially continue to operate under their current brands as “A Summit Health Company.”

The addition of NJU greatly enhances Summit Health’s urologic service line and complements its cancer services. “NJU’s more than 150 urologists, radiation oncologists, medical oncologists, and clinicians have chosen to partner with Summit Health due to our shared commitment to the highest quality of integrated patient care,” added Dr. Martin Goldstein.

READ THE PRESS RELEASE   |  PATIENT FAQS

Cancer Care Center | Medical Oncology in Saddle Brook, NJ

New Jersey Urology Opens New Cancer Care Center in Saddle Brook, NJ

New Jersey Urology (NJU) is pleased to announce the opening of a brand-new Cancer Care Center in Saddle Brook, New Jersey. This NJU Cancer Care Center offers the most comprehensive oncology care with state-of-the-art treatment in a safe and compassionate environment.

Dr. Elan Diamond, Director of Medical Oncology, will lead the Cancer Care Center at Saddle Brook. Dr. Diamond is a board-certified genitourinary oncologist specializing in the care of prostate, bladder, kidney, penile, and testicular cancers. As Director of NJU’s oncology program, Dr. Diamond is committed to treating his patients with the most compassionate care possible and providing access to the most important clinical trials in urologic oncology. He will continue to see patients at NJU’s Cancer Treatment Centers in Bloomfield and West Orange, NJ.

The new 11,500+ square foot facility was designed with patient access, education, and comfort in mind. Six exam rooms and a 20-chair infusion center will allow for easier patient access to clinical office visits. In addition to Dr. Diamond, the dedicated Cancer Care Center staff includes a clinical pharmacist who is specialty trained in oncology medicine as well as oncology-certified registered nurses. The clinical and navigation teams work collaboratively to ensure each patient gets the personalized care and attention they need.

Cancer Care Center patients will also have access to specialized on-site laboratory services and clinical research programs as directed by their care team.

Cancer Care Center at Saddle Brook
160 Pehle Avenue, Suite 400
Saddle Brook, NJ 07663
(973) 873-7029

GreenLight_Hero_Image

Dr. Thomas Chun Designated as a Center of Excellence for GreenLight™ Laser Therapy

Center of Excellence Recognizes High Degree of Experience with New Technology

We’re pleased to announce that Dr. Thomas Chun has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Chun’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.1

BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2

“Being designated as a GreenLight Center of Excellence is a meaningful recognition for us, as we strive to provide the best possible treatment of urological conditions for patients in the Bergen County area,” said Dr. Chun. “For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery. However, medications may not work for everyone and may have undesirable side effects such as dizziness, sexual dysfunction, and lower sex drive.3 With GreenLight Therapy, we’re able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants.”

GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1

GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.3

 


1. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.

2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph).

3. Data on file with Boston Scientific.

* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural

NJU Physicians Selected as New Jersey Monthly 2021 Top Doctors

We’re proud to announce that 19 New Jersey Urology physicians have been honored as 2021 Jersey Choice Top Doctors by New Jersey Monthly Magazine.

More than 26,000 New Jersey–based doctors were invited to recommend the physicians they would choose to treat their own family members.

2021 Jersey Choice Top Doctors in Urology:

See New Jersey Monthly’s complete list here >

NJU Physicians Selected as South Jersey Magazine 2021 Top Physicians

South Jersey Magazine 2021 Top PhysiciansWe’re proud to announce that five New Jersey Urology physicians have been honored as South Jersey Magazine 2021 Top Physicians! These physicians were chosen by their peers and South Jersey Magazine readers for the trusted care they provide and the manner in which they do so.

South Jersey Magazine 2021 Top Physicians in Urology:

Read South Jersey Magazine’s complete list here >

Castle Connolly Names Area’s Top Doctors 2021

castle_connolly_top_docsWe are proud to announce that 34 New Jersey Urology physicians have been honored as Castle Connolly Top Doctors for 2021!

Castle Connolly Medical Ltd., a New York City-based research and information company, selects the top 10 percent of the region’s physicians by conducting a peer-reviewed survey. Licensed physicians vote for the doctors they view as exceptional, and the Castle Connolly physician-led research team tabulates the results and vets the nominee pool, confirming the doctors’ board certifications and licensing, and investigating their disciplinary histories.

2021 TOP DOCTORS IN UROLOGY:

TOP DOCTORS IN MEDICAL ONCOLOGY:

TOP DOCTORS IN RADIATION ONCOLOGY:

View the complete list here  >

NJU Pathology Lab Grand Opening Ribbon-cutting ceremony

GRAND OPENING OF NJU’S WORLD-CLASS PATHOLOGY LABORATORY

New Jersey Urology (NJU) unveiled their newly renovated pathology laboratory on Wednesday, July 14, 2021. This state-of-the-art lab offers world-class pathology services by integrating diagnostic excellence and unparalleled service.

New Jersey Urology’s Grand Opening ribbon-cutting ceremony was hosted by COO Victor Houtz, and speeches were given by CEO Scott Ciccarelli, Dr. Marty Goldstein, President, Dr. Adnan Savera, Executive Vice President and Medical Director, and honored guest Bloomfield Mayor Michael Venezia.

NJU-diagnostics-lab-employees

NJU DIAGNOSTICS: DR. ADNAN SAVERA AND LAB EMPLOYEES

NJU DIAGNOSTICS PATHOLOGY LABORATORY

Located in Bloomfield, New Jersey, the 7,866 sq. ft. pathology laboratory, designed by Posen Architects, LLC and constructed by the Walsh Group, offers a world-class lab with state-of-the-art instruments, specialized and efficient processes for high throughput testing, and high quality results. Newly added is its Molecular department, which will further advance NJU’s diagnostic armamentarium. NJU Diagnostics, a division of New Jersey Urology, has invested in cutting-edge molecular platforms, including PCR and Next Gen Sequencing, and new molecular assays include genetic testing for personalized care of oncology patients, COVID -19 testing, and PCR-based assay for UTI.

With this expansion, NJU Diagnostics now offers several anatomic and clinical pathology testing modalities and receives approximately 1,000 new specimens a day, performing over 27,000 tests monthly, totaling approximately 330,000 annually.

“As our understanding of cancer becomes more clear, it is apparent that successful treatment must be personalized,” said Dr. Martin Goldstein, President of New Jersey Urology. “The opening of this lab will help us individualize our cancer treatment based on one’s own genetic makeup and assist us in providing better prognostic information to our patients and their families.”

Leading the charge, and a nationally recognized GU pathologist, is Dr. Adnan Savera, Executive Vice President and Medical Director of NJU Diagnostics. Dr. Savera is an elected Fellow of the International Society of Urological Pathology and College of American Pathologists and a member of the American Urological Association.

“Today’s ceremony is a tangible reminder of our mission…deliver the highest quality and cutting-edge laboratory services,” said Dr. Adnan Savera. “This has been possible, in part, by our unwavering commitment to Innovation and Excellence – which is in our DNA, and our renovated facility and new test offerings are a bold reflection of this commitment.”

“With the introduction and continued investment into these cutting-edge, personalized services, we are delivering on our commitment of advancing care and improving patient outcomes,” said Scott Ciccarelli, CEO.

View the full press release >

GreenLight_Hero_Image

Dr. Aryeh Keehn Designated as a Center of Excellence for GreenLight™ Laser Therapy

Center of Excellence Recognizes High Degree of Experience with New Technology

Dr. Aryeh Keehn Urologist Bayonne Rahway West Orange NJWe’re pleased to announce that Dr. Aryeh Keehn has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Keehn’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.1

BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2

GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1

GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.3

 


1. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.

2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph).

3. Data on file with Boston Scientific.

* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural

1 2 3 6

Search

+
Skip to content